Medical Microbiology and Immunology

, Volume 181, Issue 2, pp 77–86

SA-11 rotavirus binding to human serum lipoproteins

  • Fabiana Superti
  • Lucilla Seganti
  • Magda Marchetti
  • Maria Luisa Marziano
  • Nicola Orsi
Original Investigations


An investigation of SA-11 rotavirus binding to human serum lipoproteins was carried out. Various subclasses of lipoproteins, purified by ultracentrifugal flotation, and apoproteins were tested for their activity in inhibiting viral infectivity and hemagglutination. All tested lipoprotein subclasses (very low, low and high density, lipoproteins: VLDL, LDL, HDL, HDL1) were shown to interact with SA-11 rotavirus: VLDL and LDL were the most active in preventing rotavirus replication, whereas HDL and HDL1 inhibited viral hemagglutination to a greater extent. Moreover, A1 and A2 apoproteins were effective towards both viral infectivity and hemagglutination. Results obtained are in agreement with a preferential interaction of VP7 or VP4 proteolytic products with low density lipoproteins and of VP8* with high density lipoproteins. Binding of SA-11 to lipoproteins or apoproteins was also quantified by an enzyme-linked immunosorbent assay procedure and lipoproteins-virus interaction was visualized by electron microscopy.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bartlett AV, Bednars-Prashad AJ, Du Pont HL, Pickering LK (1987) Rotavirus gastroenteritis. Annu Rev Med 38:399–451Google Scholar
  2. Bass DM, Mackow ER, Greenberg HB (1991) Identification and partial characterization of a Rhesus rotavirus binding glycoprotein on murine enterocytes. Virology 183:602–610Google Scholar
  3. Bastardo JW, Holmes IH (1980) Attachment of SA-11 rotavirus to erythrocyte receptors. Infect Immun 29:1134–1140Google Scholar
  4. Bastardo JW, McKimm-Breschkin JL, Sonza S, Mercer LD, Holmes IH (1981) Preparation and characterization of antisera to electrophoretically purified SA-11 virus polypeptides. Infect Immun 34:641–647Google Scholar
  5. Estes MK (1990) Rotaviruses and their replication. In: Fields BN (ed) Virology. Raven Press, New York, pp 1329–1352Google Scholar
  6. Fiore L, Greenberg HB, Mackow ER (1991) The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin. Virology 181:553–563Google Scholar
  7. Fukudome K, Yoshie O, Konno T (1989) Comparison of human, simian, and bovine rotavirus for requirement of sialic acid in hemagglutination and cell adsorption. Virology 172:196–205Google Scholar
  8. Greenberg HB, Valdesuso J, van Wyke K, Midthun K, Walsh M, MacAuliffe V, Wyatt RG, Kalica AR, Flores J, Hoshino Y (1983) Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus. J Virol 125:267–275Google Scholar
  9. Horowitz MI (1977) Gastrointestinal glycoproteins. In: Horowitz MI, Pigman W (eds) The glycoconjugates, vol 1. Academic Press, New York, pp 189–213Google Scholar
  10. Huemer HP, Menzel HJ, Potratz D, Brake B, Falke D, Utermann G, Dierich MP (1988) Herpes simplex virus binds to human serum lipoprotein. Intervirology 29:68–76Google Scholar
  11. Keljo DJ, Smith A (1988) Characterization of binding of simian rotavirus SA-11 to cultured epithelial cells. J Pediatr Gastroenterol Nutr 7:249–256Google Scholar
  12. Lentz TL (1990) The recognition event between virus and host cell receptor: a target for antiviral agents. J Gen Virol 71:751–766Google Scholar
  13. Little LM, Shadduck JA (1982) Pathogenesis of rotavirus infection in mice. Infect Immun 38:755–763Google Scholar
  14. Makabe T, Sato M, Ouneda S, Inaba Y (1986) Hemagglutination with ovine rotavirus. Arch Virol 90:153–158Google Scholar
  15. Mastromarino P, Seganti L, Orsi N (1980) Relationship between enzymatic modifications of serum low density lipoproteins and their hemagglutination inhibiting activity towards Sindbis virus. Arch Virol 65:37–44Google Scholar
  16. Matsui SM, Offit PA, Vo PT, Mackow ER, Benfield DA, Shaw RD, Greenberg HB (1989) Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic neutralization domain of VP7 and VP8 fragment of VP4. J Clin Microbiol 27:780–782Google Scholar
  17. Offit PA, Shaw RD, Greenberg HB (1986) Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins VP3 and VP7. J Virol 58:700–703Google Scholar
  18. Redgrave TG, Roberts DCK, West CE (1975) Separation of plasma lipoproteins by density gradient ultracentrifugation. Anal Biochem 65:42–49Google Scholar
  19. Ruggeri FM, Greenberg HB (1991) Antibodies to the trypsin cleavage peptide VP8* neutralize rotavirus by inhibiting binding of virions to target cells in culture. J Virol 65:2211–2219Google Scholar
  20. Shaw RD, Vo PT, Offit PA, Coulson BS, Greenberg HB (1986) Antigenic mapping of the surface proteins of rhesus rotavirus. Virology 155:434–451Google Scholar
  21. Soutar AK, Myant NB (1979) Plasma lipoproteins. In: Offord RE (ed) Chemistry of macromolecules IIB macromolecular complexes. University Park Press, Baltimore, pp 55–119Google Scholar
  22. Superti F, Donelli G (1991) Gangliosides as binding sites in SA-11 rotavirus infection of LLCMK2 cells. J Gen Virol 72:2467–2476Google Scholar
  23. Superti F, Marchetti M, Seganti L, Conte MP, Orsi N (1991) Human serum non-antibody inhibitors towards SA-11 rotavirus hemagglutination. Microbiologica 14:25–30Google Scholar
  24. Taniguchi K, Morita Urasawa T, Urasawa S (1987) Cross-reactive neutralization epitopes on VP3 of human rotavirus, analysis with monoclonal antibodies and antigenic variants. J Virol 61:1726–1730Google Scholar
  25. Willoughby RE, Yolken RH (1990) SA-11 rotavirus is specifically inhibited by an acetylated sialic acid. J Infect Dis 161:116–119Google Scholar
  26. Willoughby RE, Yolken RH, Schnaar RL (1990) Rotaviruses specifically bind to the neutral glycosphingolipid asialo-GM1. J Virol 64:4830–4835Google Scholar
  27. Yolken RH, Willoughby R, Wee S, Miskuff R, Vonderfecht S (1987) Sialic acid glycoproteins inhibit in vitro and in vivo replication of rotaviruses. J Clin Invest 79:148–154Google Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • Fabiana Superti
    • 1
  • Lucilla Seganti
    • 2
  • Magda Marchetti
    • 2
  • Maria Luisa Marziano
    • 1
  • Nicola Orsi
    • 2
  1. 1.Laboratorio di Ultrastrutture, Istituto Superiore di SanitàRomeItaly
  2. 2.Istituto Pasteur-Fondazione Cenci Bolognetti, Istituto di Microbiologia, Università “La Sapienza”RomeItaly

Personalised recommendations